A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Phase of Trial: Phase II
Latest Information Update: 21 Mar 2017
Price : $35 *
At a glance
- Drugs Trichuris suis ova (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 04 Mar 2016 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 28 Apr 2015 Planned End Date changed from 1 Sep 2016 to 1 Nov 2015 as per ClinicalTrials.gov record.
- 28 Apr 2015 Planned primary completion date changed from 1 Mar 2016 to 1 Nov 2015 as per ClinicalTrials.gov record.